Regan Miles was named Vice Chairman of Unigen, Inc. effective August 1, 2021. His transition from President & CEO to Vice Chairman is fundamental to the company’s succession planning and positioning for the future and rapid growth of Unigen.
Mr. Miles began his career with Unigen in 2002 as EVP of Sales & Marketing. He served two terms as Unigen’s President and CEO, from 2006-2008 and 2015-2021. During his time with Unigen, Mr. Miles has been instrumental in growing the business from a new research and development firm to a profitable patented ingredient supplier. Under his leadership the biotech company launched 10 proprietary branded ingredients that ultimately brought to fruition the vision and mission of “Bringing the best of nature to humankind.”
Mr. Miles has 30+ years of experience in the natural products industry. He has held top leadership positions with many of the leading companies in the industry including Nature’s Way, Pharmanex, Integrative Therapeutics, Univera and Next Pharmaceuticals. He has demonstrated a strong record of success in achieving growth and profitability at the companies he has been associated with. As Vice Chairman, Mr. Miles shares his industry knowledge, working in collaboration and mentoring Unigen’s new executive leadership.
Dr. Qi Jia, Ph.D., was named President & CEO, Unigen, Inc., effective August 1, 2021. Dr. Jia has worked for the company 25 years since Unigen’s inception in 1996. The promotion to President & CEO is part of Unigen’s succession planning and positioning for its future and rapid growth.
Since joining Unigen as Director of Natural Products in 1996, Dr. Jia has established collaborations with multiple organizations around the world to collect indigenous medicinal plants and has built up a proprietary natural products library and the discovery platform, PhytoLogix®, with thousands of collections. He has lead product development and commercialization of nutritional and cosmetic ingredients with expanded responsibility as Vice President of Product Development between 1999 – 2004 and as Chief Scientific Officer from 2004-2021.
Dr. Jia holds 107 issued international patents and has 73 peer-reviewed publications and 64 oral or poster presentations at professional conferences in the field of natural products research. The ingredients Univestin® and Nivitol®, co-invented by Dr. Jia and Unigen scientists, have been utilized by global brands in joint health and even skin tone products.
Dr. Jia received his B.S. in Medicinal Chemistry from Beijing Medical University in 1985 and a Ph.D. in Organic Chemistry from Texas Christian University in 1995. Dr. Jia has studied ethnomedicinal plants for over 35 years. He has demonstrated a strong leadership and record of success in natural products discovery, development, commercialization and establishment of R&D collaborations with universities, institutes and industry partners.
As President and CEO, Dr. Jia will lead Unigen through the substantial growth trend forecasted for the biotech company and continue to fulfill its global vision of “Bringing the best of nature to humankind.”
Dr. Ma has extensive experience in quality control and quality assurance management developed in multiple pharmaceutical and biotechnology companies. She has a strong background in the areas of analytical and natural product chemistry. Her proven experience involving Current Good Manufacturing Practices (cGMP) regulations and compliance supports Unigen in establishing and maintaining a higher level of quality standards and systems in the dietary supplement industry.
Dr. Ma has a Ph.D. in Natural Product Chemistry from the Department of Medicinal Chemistry and Pharmacognosy Pharmacy School at Purdue University, Indiana . She received her Bachelor’s degree in Pharmaceutical Sciences from the School of Pharmacy , Shanghai First Medical College , China. Her work has been published in more than 20 peer-reviewed publications, and she has received a number of awards and honors for her contributions in the areas of natural product chemistry, pharmacognosy and new drug discovery.
Ms Brownell joined Unigen in 2007, she has extensive experience in clinical research, laboratory science, regulatory and healthcare management developed in multiple pharmaceutical, biotechnology, academic and healthcare companies. Her experience in involving Good Clinical Practices (GCP) regulations and compliance supports Unigen’s clinical trials and regulatory filings.
Ms Brownell has a degree in Health Services Management from Webster University, Saint Louis, MO and a Biology and Medical Technology Degree Creighton University School of Pharmacy and Allied Health Sciences, Omaha, Nebraska. She has co-authored multiple publications and patents and is an active member of various professional associations.